NSPR earnings: next report 2026-08-03, real EPS beat/miss history, analyst consensus Buy, P/E -1.23. Updated 2026-07-23.
InspireMD (NSPR) Research Hub
InspireMD (NSPR) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 0.7899 USD (-0.01%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.23, market cap 0.03B. This hub links to the full technical, earnings and options research available for NSPR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.7899 USD (-0.01%) |
| 52-week range | 0.63 USD – 1 USD |
| Trend regime | Range |
| 14-day RSI | 55 (Neutral) |
| Trailing P/E | -1.23 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-03 |
Available research for NSPR
Covered Call on NSPR: how it works, illustrative setup around the real 0.7899 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NSPR: how it works, illustrative setup around the real 0.7899 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NSPR: how it works, illustrative setup around the real 0.7899 USD price, max profit/loss, breakeven and when to use it. Educational.
NSPR technical analysis: range, last 0.7899 USD, RSI 55, 52w range 0.63 USD–1 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is NSPR in?
InspireMD (NSPR) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is NSPR in an uptrend or downtrend?
As of 2026-09-11, NSPR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NSPR's trailing P/E ratio?
NSPR's trailing P/E is -1.23, with a market cap of 0.03B. See the earnings research page for full valuation detail.
When does NSPR next report earnings?
NSPR is next scheduled to report earnings on 2026-08-03, with a consensus EPS estimate of -0.2 USD.